ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281613; 2) Community: the network communities that were significantly associated with the response to NSC 281613; 3) Molecule: the relationships between components within communities and NSC 281613; 4) MDR: the compounds that were significantly associated with the NSC 281613.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 0.0247898374452139 0.51461133
NSC 626108 Null 0.0247898374452139 0.0070857515
NSC 637009 Null 0.0247898374452139 0.13545844
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.0247898374452139 0.19858014
NSC 644043 Null 0.0247898374452139 0.33468367
NSC 667707 Null 0.0247898374452139 0.25063039
NSC 676372 Null 0.0247898374452139 0.085883
NSC 676779 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop 0.0247898374452139 -0.21036584
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0247898374452139 -0.015132994
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0247898374452139 0.11617397
Total:61  Current:32    [First] [Prev] [Next] [Last]